Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Detection of mutations by automated fluorescence/RNA-based dideoxy fingerprinting (ARddF)

An Erratum to this article was published on 25 May 1999

Abstract

Dideoxy fingerprinting (ddF) is a hybrid technique which combines aspects of single strand conformational polymorphism (SSCP) and dideoxy sequencing to detect the presence of single base changes in a defined fragment of nucleic acid. ddF is no more technically demanding than SSCP, yet it is more sensitive in detecting point mutations. We describe here the adaptation of conventional ddF to an automated sequencing system using fluorescent Cy5 labeled primers. We show that automated RNA-based ddF (ARddF) has several advantages over conventional radioisotope-based ddF, including: (1) analysis of larger nucleic acid fragments (up to 103 bp), due to the ability to continuously analyse and compile sequencing information; (2) greater reliability for distinguishing mutant sequences from wild type sequences (particularly when the mutation leads to gain or loss of a dideoxy termination segment); (3) the use of fluorescent labeled primers, making ARddF less hazardous than methods requiring radionucleotides. The use of ARddF in conjunction with new methods for isolating RNA from a small number of cells facilitates mutational analysis of small tissue biopsies and other limited samples, and will allow more widespread application of mutational screening in the setting of clinical diagnostic laboratories.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • ALF express DNA Sequencer. . (1996) User Manual, Pharmacia Biotech.

  • Ben-David Y, Prideaux VR, Chow V, Benchimol S and Bernstein A. . 1988 Oncogene 3: 179–186.

  • Blaszyk H, Hartmann A, Schroeder JJ, McGovern RM, Sommer SS and Kovach JS. . 1995 BioTechniques 18: 256–260.

  • Chomczynski P and Sacchi N. . 1986 Anal. Biochemistry 162: 156–159.

  • Chen HL and Carbone DP. . 1997 Mol. Med. Today 3: 160–167.

  • Durocher F, Tonin P, Shattuck-Eidens D, Skolnick M, Narod SA and Simard J. . 1996 J. Med. Genetics 33: 814–819.

  • Grompe M. . 1993 Nature Genetics 5: 111–117.

  • Hamada M, Fujiwara T, Hizuta A, Gochi A, Naomoto Y, Takakura N, Takahashi K, Roth JA, Tanaka N and Orita K. . 1996 J. Can. Res. & Clin. Onc. 122: 360–365.

  • Koury MJ, Park DJ, Martincic D, Horne DW, Kravtsov V, Whitlock JA, Aguinaga MP and Kopsombut P. . 1997 Blood 90: 4054–4061.

  • Liu Q, Feng J and Sommer SS. . 1992 Hum. Mol. Gen. 5: 107–114.

  • Liu Q and Sommer SS. . 1995 BioTechniques 18: 470–477.

  • Martincic D and Whitlock JA. . 1996 Oncogene 13: 2039–2044.

  • Martincic D, Zimmerman SA, Ware RE, Sun MF, Whitlock JA and Gailani D. . 1998 Blood. In Press.

  • Miyata I, Cogan JD, Prince MA, Kamijo T, Ogawa M and Phillips 3rd JA. . 1997 Endocrine J. 44: 149–154.

  • Moreau-Gachelin F, Ray D, Mattei M-G, Tambourin P and Tavitian A. . 1989 Oncogene 4: 1449–1454.

  • Olsen LS, Nielsen LR, Nexo BA and Wassermann K. . 1996 Pharmacol. Toxicol. 78: 364–373.

  • Orita M, Iwahana H, Kanazawa H, Hayashi K and Sekiya T. . 1989 Proc. Natl. Acad. Sci. USA 86: 2766–2770.

  • Pennica D, Goeddel DV, Hayflick JS, Reich NC, Anderson CV and Levine AJ. . 1984 Virology 134: 477–482.

  • Puck JM, Middelton L and Pepper AE. . 1997 Hum. Genet. 99: 628–633.

  • Puck JM, Pepper AE, Henthorn PS, Candotti F, Isakov J, Whitwam T, Conley ME, Fischer RE, Rosenblatt HM, Small TN and Buckley RH. . 1997 Blood 89: 1968–1977.

  • Quiang L and Sommer SS. . 1994 PCR Methods Applications 4: 97–108.

  • Quiang L, Sobell JL, Heston LL and Sommer SS. . 1995 Am. J. Med. Gen. 60: 165–171.

  • Sanger F, Nicklen S and Coulson AR. . 1977 Proc. Natl. Acad. Sci. USA 74: 5463–5467.

  • Sarkar G, Yoon H-S and Sommer SS. . 1992a Genomics 13: 441–443.

  • Sarkar G, Yoon HS and Sommer SS. . 1992b Nucl. Acid. Res. 20: 871–878.

  • Scriver CR, Beaudet AL, Sly WS and Valle D. . (1995) The metabolic and molecular basis of inherited disease. McGraw-Hill: New York pp.1–50.

    Google Scholar 

  • Sobell JL, Lind TJ, Hebrink DD, Heston LL and Sommer SS. . 1997 Am. J. Med. Gen. 74: 44–49.

  • Stoflet ES, Koeberl DD, Sarkar G and Sommer SS. . 1988 Science 239: 491–494.

  • Wendling F, Moreau-Gachlin F and Tambourin P. . 1981 Proc. Natl. Acad. Sci. USA 78: 3614–3619.

  • Zahurak M, Goodman SN, Westra WH, Schwab D, Yoo GH, Lee DJ, Forastiere AA and Sidransky D. . 1996 J. Nat. Cancer Inst. 88: 1580–1586.

  • Zhang WW, Alemany R, Wang J, Koch PE, Ordonez NG and Roth JA. . 1995 Human Gene Therapy 6: 155–164.

Download references

Acknowledgements

This work was supported in part by Amersham Pharmacia Biotech, in part by National Cancer Institute Cancer Center Support Grant – 1P30CA68485 (DM); Grant No. 94-B80 from the American Institute of Cancer Research and a Merit Review grant from the Department of Veterans Affairs (MJK).

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Martincic, D., Koury, M., Gale, K. et al. Detection of mutations by automated fluorescence/RNA-based dideoxy fingerprinting (ARddF). Oncogene 18, 617–621 (1999). https://doi.org/10.1038/sj.onc.1202295

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1202295

Keywords

Search

Quick links